Azitra Inc AZTR

Morningstar Rating
$0.52 −0.01 (2.75%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AZTR is trading at a LOCK|!^CRk premium.
Price
$0.53
Fair Value
LOCK|r!VD@Rz
Uncertainty
LOCK|Yc #<!K
1-Star Price
LOCK|jH$sZjT
5-Star Price
LOCK|T$<@qDc
Economic Moat
LOCK|J>^J
Capital Allocation
—

News

Trading Information

Previous Close Price
$0.53
Day Range
$0.51–0.55
52-Week Range
$0.51–3.91
Bid/Ask
$0.50 / $0.59
Shares Outstanding
6.06M
Market Cap
$3.13M
Volume/Avg
56,165 / 3M

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
—
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Azitra Inc is a clinical-stage biopharmaceutical company focused on developing therapies for precision dermatology and novel products across therapeutics, cosmeceuticals, and biotechnology applications. The Company's portfolio is highlighted by ATR-COSF, a recombinant protein technology designed for cosmetic and skincare applications, and ATR-04, an investigational live biotherapeutic for skin rashes associated with cancer and neurofibromatosis treatments. Its technology platforms combine engineered proteins, topical live biotherapeutics, artificial intelligence, and a proprietary microbial library to develop differentiated products for consumer, research, and healthcare markets.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
13

Valuation

Metric
AZTR
Price/Earnings (Normalized)
—
Price/Book Value
0.73
Price/Sales
—
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
AZTR
Quick Ratio
2.52
Current Ratio
3.11
Interest Coverage
−1,230.72
Quick Ratio
AZTR

Profitability

Metric
AZTR
Return on Assets (Normalized)
−162.74%
Return on Equity (Normalized)
−209.05%
Return on Invested Capital (Normalized)
−197.07%
Return on Assets
AZTR

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
LOCK|@?z?BWnLOCK|z$qyj$132B
Regeneron Pharmaceuticals Inc
REGN
LOCK|!ZVg<s&LOCK|j>?G?$96B
Moderna Inc
MRNA
LOCK|@^>zr>dLOCK|@cp$81B
argenx SE ADR
ARGX
LOCK|%qYwbJLOCK|%@$59B
BeOne Medicines Ltd ADR
ONC
LOCK|X>kS<?LOCK|Lb$47B
Royalty Pharma PLC Class A
RPRX
LOCK|>n%Tb$dLOCK|%&QfG$30B
Incyte Corp
INCY
LOCK|H$&kD@LOCK|df$24B
BioNTech SE ADR
BNTX
LOCK|kG$P>nLOCK|RS^$20B
Alnylam Pharmaceuticals Inc
ALNY
LOCK|@k#>>RLOCK|Kwy<&$20B
BridgeBio Pharma Inc
BBIO
LOCK|$jK?$!?LOCK|%m$15B

Sponsor Center